Literature DB >> 214684

HBsAg-negative chronic active hepatitis related to hepatitis B virus.

A Goudeau, P Coursaget, J Drucker, P Maupas, P Borie, J P Benhamou.   

Abstract

Numerous cases of chronic hepatitis have been shown to be closely associated with persistent infection with hepatitis B virus (HBV). A group of 100 patients suffering from chronic active hepatitis (CAH) was investigated for HBV serologic markers. Of these, 35 patients were HbsAg-positive; in 26 HBsAg-negative subjects, anti-HBc were detected using counterimmune electrophoresis and complement-fixation tests. These data suggest that chronic liver disease in patients who were only anti-HBc-positive might be related to persistent infection with hepatitis B virus. Epidemiological clinical and histopathological data were different when we compared CAH patients who were HBsAg-negative, but anti-HBc-positive, with HBsAg-positive CAH patients. A sequence is proposed leading from HBsAg-positive to HBsAg-negative CAH, cirrhosis, and hepatoma in temperate areas, according to a model similar to the one described in intertropical Africa.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 214684     DOI: 10.1007/bf02121155

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  22 in total

1.  Automation of immune hemolytic and complement reactions by autoanalyzer. I.

Authors:  R Vargues; W Henley
Journal:  Mt Sinai J Med       Date:  1974 Mar-Apr

2.  Cytoplasmic localisation of Australia antigen in the liver.

Authors:  S Hadziyannis; A Moussouros; C Vissoulis; A Afroudakis
Journal:  Lancet       Date:  1972-05-06       Impact factor: 79.321

3.  Antibody to hepatitis B core antigen. A sensitive indicator of hepatitis B virus replication.

Authors:  J H Hoofnagle; R J Gerety; L Y Ni; L F Barker
Journal:  N Engl J Med       Date:  1974-06-13       Impact factor: 91.245

4.  Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications.

Authors:  D Doniach; I M Roitt; J G Walker; S Sherlock
Journal:  Clin Exp Immunol       Date:  1966-07       Impact factor: 4.330

5.  Significance of anti-HBc in patients with hepatic disease. A comparative immunohistochemical study of blood and hepatic tissue.

Authors:  L Kater; A J Vogten
Journal:  Am J Clin Pathol       Date:  1976-10       Impact factor: 2.493

6.  Antibody to hepatitis-B core antigen in patients with primary hepatic carcinoma.

Authors:  P Maupas; B Werner; B Larouzé; I Millman; W T London; A O'Connell; B S Blumberg
Journal:  Lancet       Date:  1975-07-05       Impact factor: 79.321

7.  Letter: Core antigen in chronic active hepatitis.

Authors:  J P Benhamou; P Maupas; B Pillegand
Journal:  Lancet       Date:  1976-04-10       Impact factor: 79.321

8.  Viral hepatitis: clinical aspects.

Authors:  A G Redeker
Journal:  Am J Med Sci       Date:  1975 Jul-Aug       Impact factor: 2.378

9.  [The rate constant K37 in complement fixation tests: kinetic studies on the influenza virus-immune complex model (author's transl)].

Authors:  P Coursaget; P Maupas; R Vargues
Journal:  Ann Microbiol (Paris)       Date:  1976 Aug-Sep

10.  Relationship of hepatitis-associated antigen (H.A.A.) to acute and chronic liver injury.

Authors:  F J Dudley; R A Fox; S Sherlock
Journal:  Lancet       Date:  1971-07-03       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.